NeuroKit® Testing Platform: A Smarter Start to CNS Development
Does Your Drug Cross the Blood Brain Barrier? Does It Show Pharmacological Effects on the Central Nervous System?
Get the answers you need for decision-making in early-phase development for neurological or psychiatric disorders.
NeuroKit® brings 35+ years of validated science into a portable, plug-and-play CNS testing platform. Developed by the Centre for Human Drug Research (CHDR), and available in the U.S. through Lotus Clinical Research and Evolution Research Group (ERG), NeuroKit delivers high-quality, standardized CNS assessments.
Adapted from CHDR’s flagship NeuroCart® system, NeuroKit condenses a full suite of neurocognitive, motor, and sensory tests into a scalable format—making it easier than ever to integrate robust CNS pharmacodynamic data into your Phase I–IIa trials.
Validated Suite of Neuropsychological and Neurophysiological Tests
Designed to measure a wide range of central nervous system functions
Adaptive tracking
Attention, visuomotor coordination, fine motor skills
Body Sway
N-back test
VAS Bond & Lader
VAS Bowdle
Saccadic Eye Movement Measurement
Smooth Pursuit Eye Movement
Finger tapping Test
From the Netherlands to the US
For years, CHDR’s industry-leading CNS testing platform, NeuroCart, was only available at their clinical site in the Netherlands, which limited access to this powerful pharmacodynamic insight. Breaking through that limitation, NeuroKit is available for use in the United States for the first time, through a U.S. partnership with Lotus and ERG. Clinical Pharmacology of Miami (CPMI), ERG’s state-of-the-art Phase I unit, is the first US site to deploy the platform.
Watch NeuroKit in Action
Whether you’re testing a CNS-active compound or monitoring potential neurological effects, NeuroKit offers an unparalleled tool for early signal detection and strategic decision-making.
Connect With Us
Ready to integrate NeuroKit into your next trial? Want a deeper look at the platform’s capabilities?
Let’s talk. Fill out the form below to connect with our scientific leadership and clinical operations teams.
